Women's Imaging
NewYork-Presbyterian Queens was recently recognized as the borough’s only hospital to be named a “Breast Imaging Center of Excellence” by the American College of Radiology after a rigorous review process to ensure compliance with nationally accepted standards.
According to the American College of Radiology, a facility receives the distinction "Breast Imaging Center of Excellence” after it demonstrates excellence in breast imaging by successfully achieving accreditation in mammography, stereotactic breast biopsy, breast ultrasound and ultrasound-guided breast biopsy. The Commission on Quality and Safety and the Commission on Breast Imaging performed the ACR review.
Board-certified physicians and medical physicists considered experts in the field determined that NewYork-Presbyterian/Queens has achieved high practice standards in image quality, personnel qualifications, facility equipment, quality control procedures and quality assurance programs.
State-of-the-Art Equipment & Professional Service
The Women's Imaging Center offers the latest imaging procedures performed by board-certified radiologists, physician, and highly trained technologists on the most advanced imaging equipment available. The breast imaging service at New York Hospital Queens has become a major referral center over the past decade for specific problems of mammographic diagnosis.
Mammography
The Women's Imaging Center has vast experience in breast imaging, including both regular screening and diagnostic mammography for those with a diagnosed problem. Each week, approximately 150 mammograms are performed under the close supervision of a radiologist who is a member of the Society for Breast Imaging. The center operates two dedicated mammography units.
Conventional mammograms provide a two-dimensional image of a three dimensional breast and overlapping layers of tissue can sometimes create unclear results. 3D Mammography allows doctors to see breast tissue layer by layer, making the fine details of the breast tissue more visible. This technology enables screening for breast cancer with much greater accuracy, regardless of the patient’s age or breast density, reducing the chance of callbacks by up to 40%.(1)
3D Mammography
We offer this new, clinically proven, innovative screening technology that allows for better, more accurate detection in the fight against breast cancer, finding 20-65% more invasive breast cancers than 2D technology.(2) To verify coverage of this new technology, we recommend that you contact your insurance company prior to making an appointment.
Stereotactic needle biopsies and fine needle aspirations are available and performed upon request. In addition, the staff frequently performs localizations prior to ambulatory surgical biopsy. Pathological correlation is done on all biopsies.
Biopsy Procedure
The patient lies face down on a special table. The patient’s breast rests through an opening in the table and is gently compressed while the radiologist makes the necessary calculations on the area of concern. Once the site is targeted an injection of local anesthetic is given to the breast. A small skin nic of about a 1/4-inch is made. A probe is then inserted and gently cuts, vacuums and removes tissue samples. Multiple specimens are taken without removing and reinserting the device. The radiologist may place a tiny titanium marker to identify the biopsy site for any future surgery or to follow-up on the area. After the procedure only an adhesive strip needs to be applied. The patient can resume normal activities.
Ultrasound
Ultrasound of the breast, as well as ultrasound guided biopsies, are performed by board-certified radiologists.All outpatient obstetrical-gynecological ultrasound examinations are performed in The Obstetrical/Gynecological Department. Fetal echocardiography is performed in conjunction with pediatric cardiologists, and amniocentesis in conjunction with referring obstetricians. MRI
Breast MRI Imaging and spectroscopy MRI guided breast biopsy are available.
(1) (2)A multi-site (13), non-randomized, historical control study of 454,000 screening mammograms as published in JAMA 311.24 (2014): 2499-2507.